Clinical Trial Update: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and potential efficacy of Trappsol Cyclo in patients with early Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Trappsol Cyclo (Hydroxypropyl-β-cyclodextrin)

Snippet

Sponsor: Cyclo Therapeutics, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN